Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Naloxegol, ATC A06AH03

AOK Rheinland-Pfalz/Saarland - Die GesundheitskasseEisenberg, GermanyNot disclosed712 days leftopen

Registrieren zum Speichern Documents (1)

Opportunity Score

Confidence: 60%

Complexity: low

712 days

Deadline

supplies

Contract

Deep Portfolio Analysis

Company fit score
Missing certificates
Eligibility blockers
Bid / No-Bid recommendation

Create account for AI analysis

AI Analysis Summary

Strong opportunity

This tender is an open-house model for non-exclusive discount agreements (Rabattverträge) for pharmaceuticals containing the active ingredient Naloxegol (ATC A06AH03), organized by AOK Rheinland-Pfalz/Saarland. The procedure allows any pharmaceutical company to conclude a contract without competitive selection, with uniform conditions. The contract period runs from 01.08.2026 to 31.07.2028, with rolling entry possible on the first of each month. The notice expressly states it is not a public procurement under EU directives.

Strengths

Documents available

Open procedure

Low complexity

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Only pharmaceutical companies (pharmazeutische Unternehmen) are eligible as contract partners
Must have authorized and marketable drugs containing Naloxegol in Germany
Proof of marketing authorization: drugs must be listed in Lauer-Taxe or, if not yet listed, provide AMIce database extracts showing name, marketing authorization holder, dosage form, active ingredient, and marketability

Buyer

Name

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse

Location

Eisenberg, DEU

[email protected]

Website

www.aok.de/rheinland-pfalz-saarland/

Buyer profile

Open profile

Identifier

DE271900642

Lots (1)

#LOT-0001Open house Arzneimittelrabattverträge zum Wirkstoff Naloxegol, ATC A06AH03

Non-exclusive discount agreements for Naloxegol; open to all pharmaceutical companies; uniform terms; maximum 24 months duration; earliest start 01.08.2026; rolling entry possible; contracts end simultaneously on 31.07.2028 regardless of start date; buyer reserves right to replace with exclusive contracts during term; pediatric drugs per BfArM list excluded.

33600000DEU